MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 159 filers reported holding MERSANA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $610,026 | -80.6% | 104,100 | -77.6% | 0.00% | -66.7% |
| Q3 2022 | $3,147,728 | +3051.0% | 465,600 | +2055.6% | 0.01% | – |
| Q2 2022 | $99,896 | +16.0% | 21,600 | 0.0% | 0.00% | – |
| Q1 2022 | $86,092 | -90.7% | 21,600 | -85.4% | 0.00% | -100.0% |
| Q4 2021 | $921,000 | -83.1% | 148,000 | -27.8% | 0.00% | -88.2% |
| Q4 2020 | $5,456,000 | +48.9% | 205,042 | +4.2% | 0.02% | +30.8% |
| Q3 2020 | $3,664,000 | -69.7% | 196,766 | -62.0% | 0.01% | -45.8% |
| Q2 2020 | $12,108,000 | +189.7% | 517,394 | -27.8% | 0.02% | +140.0% |
| Q1 2020 | $4,180,000 | – | 716,954 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,005,600 | $64,810,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,695,667 | $59,796,000 | 3.39% |
| COMMODORE CAPITAL LP | 429,228 | $6,945,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 357,689 | $5,787,000 | 2.09% |
| Avoro Capital Advisors LLC | 6,800,000 | $110,024,000 | 1.90% |
| Ghost Tree Capital, LLC | 450,000 | $7,281,000 | 1.71% |
| RHO CAPITAL PARTNERS INC | 796,458 | $12,887,000 | 1.24% |
| Rock Springs Capital Management LP | 2,775,127 | $44,902,000 | 0.98% |
| Sio Capital Management, LLC | 157,259 | $2,544,000 | 0.52% |
| Bellevue Group AG | 2,850,010 | $46,113,000 | 0.49% |